Foreign Patients Flock to China for Affordable, Accessible
Foreigners are increasingly pursuing life-saving care in China due to cheaper treatments and better access, fueling a rising medical tourism market and —
GSK Nuvalent acquisition talks: FT reports talks to buy
GSK Nuvalent acquisition talks are ongoing, with no official confirmation yet and a reported deal value between $9 billion and $10 billion, per the Financial
Johnson & Johnson to Acquire Halda Therapeutics in $3.05B
Johnson Johnson Halda Therapeutics is a key focus in Johnson & Johnson's strategy to expand its oncology portfolio through a $3.05 billion acquisition.